$166.99
11.437.35%
가까이에: Sep 18, 5:00 PM EST
$166.60
-0.39-0.23%
시간외: 6:31 PM EST
Benzinga
Benzinga
Benzinga
토요일, 9월 19
Twist Bioscience Corp
TWSTNASDAQ
Twist Bioscience Earnings & Forecasts
Twist Bioscience (TWST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Twist Bioscience Guidance
Twist Bioscience (TWST)는 8월 3, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $456M - $457M 범위로 예상했습니다.
이전 가이던스와 비교하여 Twist Bioscience는 매출 전망치를 이전 범위인 상향 조정됨에서 $442M - $447M로 상향 조정했습니다.
Twist Bioscience은 38과 11월 18, 2022 사이에 8월 3, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 16 times and lowered it 14 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.53 | $-0.50 | $-0.46 |
| Actual | $-0.56 | $-0.59 | $-0.50 | $-0.45 |
| Surprise | -133.3% | -11.3% | 0.00% | +2.17% |
| Revenue | ||||
| Estimate | $114.5M | $107.7M | $102.7M | $97.4M |
| Actual | $118.4M | $110.7M | $103.7M | $99.0M |
| Surprise | +3.36% | +2.80% | +0.95% | +1.69% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.11 | $-0.12 | $-0.47 | $-0.41 |
| Revenue | ||||
| Consensus | $123.5M | $125.7M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved